Milking the Benefits: Can Bovine Milk Accelerate Bone Healing?

Commentary The acceleration of fracture healing represents an important advancement in orthopaedic science and care. Despite the well-established understanding of the underlying mechanisms of the bone-healing process, complications such as nonunion and delayed union continue to negatively impact patient outcomes1,2. In recent scientific studies, the role of nutrition in optimizing bone-healing outcomes in all settings, not just in trauma, has gained considerable attention, with the use of colostrum as a nutritional adjunct emerging as a novel, innovative, and potentially cost-effective approach that may be easily accessible in both developed and lesser-developed countries3,4. In order to shed further light on this, Gouhari et al. looked at the effect of bovine colostrum supplementation in patients with an extracapsular hip fracture (ECF). They aimed to evaluate the impact of colostrum supplementation on bone healing in patients with an ECF. The authors randomly assigned patients undergoing internal fixation for an ECF to either the bovine colostrum group or the whey protein group. Their study showed that colostrum supplementation may enhance recovery and bone-remodeling processes, enhance the efficacy of rehabilitation, and even decrease the rates of specific complications during the postoperative recovery phase. Through this commentary, we wish to congratulate the authors for their well-executed article, and we reflect on the methodology and outcomes of the study. The strengths of the study include the randomized, double-blinded, comparative trial design and the use of validated tools such as the Radiographic Union Score for Hip (RUSH), Harris hip score, and Short Musculoskeletal Functional Assessment. The authors also used a clear power calculation and adhered to the CONSORT (Consolidated Standards of Reporting Trials) guidelines, thereby lending credibility to their findings5. The outcomes of the study mark a promising step forward in the exploration of nutritional adjuncts to conventional fracture care. Despite the study’s strengths, a critical although constructive note is that the follow-up period for the primary outcome was only 3 months. Besides the fact that the primary outcome was not a clinical or functional outcome but was instead a radiographic outcome, the clinical relevance of the primary and secondary outcomes should also be assessed at a slightly longer follow-up (i.e., 1 or 2 years) given the potential functional benefits for these patients. Moreover, it is unclear to what extent the observed statistical differences in the radiographic outcomes at 3 months would translate to actual functional or clinical benefits at a longer follow-up: the clinical relevance of a statistical difference of 3.4 points in the RUSH remains unknown6. Although the authors used a power calculation, the modest sample size may have limited the ability to detect complications or small effect sizes in the secondary outcomes. As mentioned by the authors, future studies that are designed as a multicenter randomized controlled trial with a larger sample size—or even, in our opinion, a large prospective registry study—and that include longer follow-up times, less heterogeneous patient groups, and a longer intervention duration are necessary to fill the research gap. Another possibility may be studying a fracture diagnosis with a higher rate of nonunion or delayed union, such as tibial, clavicle, or other high-risk fractures7. Overall, we can conclude that this well-executed study, through its exploration of a relatively novel nutritional adjunct in fracture surgery, has the potential to mark a paradigm shift in treatments for accelerated fracture healing. To build on the clinical relevance of these findings and to assess their generalizability, future studies in this domain could research the application of bovine colostrum for healing in the setting of other orthopaedic-related diagnoses, both inside and outside of the field of orthopaedic trauma. Another future direction could be further investigation of the molecular pathways and underlying mechanisms in bone healing that are influenced by colostrum, such as the potential multifactorial effects of transforming growth factor-β (TGF-β) and lactoferrin, as well as the potential anti-inflammatory properties of colostrum that lead to the suppression of nuclear factor kappa B (NF-κB) activation8,9. Once again, we congratulate the authors for addressing a critical research gap at the intersection of nutritional science and orthopaedic surgery, which has laid some stepping-stones for future advancements in this interdisciplinary field.